Identifying Heart, Lung, and Blood Disease-Causing Variants

by:

The National Institutes of Health, otherwise known as NIH, is the agency operating within the United States Department of Health and Human Services that is fundamentally responsible for all of the country's biomedical and health-related research studies.

The programs and objectives of the NIH are tailored to contribute to the achievement of their agency mission, which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

The Identifying Heart, Lung, and Blood Disease-Causing Variants Program aims to follow suit to research studies that intend to identify heart, lung, and blood disease-causing rare or lower frequency variants through the use of the extensive exome data that was discovered under the Recovery and Reinvestment Act of 2009.

The organizers of the program believe that this data will enable lung, heart and blood investigators, to focus on variants, genes, and pathways that could potentially lead them to a deeper and more thorough understanding of certain complex diseases.

  (continued...)

Identifying Heart, Lung, and Blood Disease-Causing Variants
  Page 2

About The Author

The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs.

The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.




Additional Resources



category - Health Grants

Competitive Revision for Technology Development Within Biomedical Technology Research Centers Program
The National Institutes of Health has formed a partnership with the National Center for Research Resources (NCRR) in an attempt to establish the Competitive Revision for Technology Development Within Biomedical Technology Research Centers Program.


Pilot Studies of Innovative Treatments in Mental Disorders Project
The National Institutes of Health has recently collaborated with the National Institutes of Mental Health (NIMH) to establish the Pilot Studies of Innovative Treatments in Mental Disorders Program.


Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.


National Institutes of Health funds the Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults
The National Institutes of Health has recently established a program entitled Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults wherein they intend to kick-off research studies that will create, implement, and evaluate both old and new interventions that are geared towards improving adherence to medical and behavioral regimens for HIV-positive adolescents which are 11 to 21 years old and adults who are 21 to 24 years old.






First Enterprise Business Agency (FEBA), a Nottingham-based business support organization, is a contender for two categories at the first Citi Microentrepreneurship Awards to be held this coming February.




Not for Profit Jobs in Nebraska

  Executive Director Jobs
  Substance Abuse Jobs
  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs